StonvexLoading…
StonvexStonvexStonvexCore line items from INTG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $55.59M | $35.21M | $17.91M | $64.38M |
Operating Income | $9.01M | $4.75M | $2.73M | $7.64M |
Net Income | $1.44M | $980.00K | $-535.00K | $-5.35M |
EPS (Diluted) | $0.67 | $0.46 | $-0.25 | $-2.47 |
Total Assets | $103.51M | $101.14M | $102.52M | $104.10M |
Total Liabilities | $217.45M | $215.68M | $218.03M | $218.41M |
Cash & Equivalents | $9.28M | $6.58M | $5.04M | $5.08M |
Free Cash Flow OCF − CapEx | $884.00K | $-1.75M | $-1.27M | $3.64M |
Shares Outstanding | 2.15M | 2.15M | 2.15M | 2.15M |